Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1969 1
1974 1
1976 3
1977 1
1980 1
1981 1
1982 1
1983 2
1984 3
1985 2
1986 1
1987 3
1988 2
1990 2
1991 1
1992 1
1994 3
1995 1
1996 1
1997 1
1998 3
1999 2
2000 2
2001 2
2002 2
2004 4
2005 2
2006 5
2007 3
2008 8
2009 4
2010 3
2011 2
2012 3
2013 2
2014 1
2015 1
2016 6
2017 4
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG; GRID study investigators. Demetri GD, et al. Among authors: blackstein m. Lancet. 2013 Jan 26;381(9863):295-302. doi: 10.1016/S0140-6736(12)61857-1. Epub 2012 Nov 22. Lancet. 2013. PMID: 23177515 Free PMC article. Clinical Trial.
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.
Demetri GD, van Oosterom AT, Garrett CR, Blackstein ME, Shah MH, Verweij J, McArthur G, Judson IR, Heinrich MC, Morgan JA, Desai J, Fletcher CD, George S, Bello CL, Huang X, Baum CM, Casali PG. Demetri GD, et al. Among authors: blackstein me. Lancet. 2006 Oct 14;368(9544):1329-38. doi: 10.1016/S0140-6736(06)69446-4. Lancet. 2006. PMID: 17046465 Clinical Trial.
Gastrointestinal stromal tumours: etiology, pathology and clinical management.
Blackstein ME, Dubé P, Fletcher JA, Keller OR, Knowling M, Létourneau R, Morris D, Riddell R, Rorke S, Swallow CJ; Canadian Advisory Committee on GIST. Blackstein ME, et al. Can J Gastroenterol. 2004 Sep;18 Suppl B:3B-8B. doi: 10.1155/2004/238037. Can J Gastroenterol. 2004. PMID: 15457300 Review.
Hormones and cancer.
Blackstein ME. Blackstein ME. Can Fam Physician. 1984 Jun;30:1341-4. Can Fam Physician. 1984. PMID: 21278945 Free PMC article.
Painful palatal swelling.
Klieb HB, Duchnay M, Skeete D, Leong IT, Blackstein ME. Klieb HB, et al. Among authors: blackstein me. Lancet. 2010 Apr 3;375(9721):1224. doi: 10.1016/S0140-6736(10)60053-0. Lancet. 2010. PMID: 20362816 No abstract available.
Bone marrow metastasis of angiosarcoma.
Wang C, Rabah R, Blackstein M, Riddell RH. Wang C, et al. Among authors: blackstein m. Pathol Res Pract. 2004;200(7-8):551-5. doi: 10.1016/j.prp.2004.05.003. Pathol Res Pract. 2004. PMID: 15462503 Review.
Dose-intensive chemotherapy with growth factor or autologous bone marrow/stem cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a systematic review.
Verma S, Younus J, Stys-Norman D, Haynes AE, Blackstein M; Sarcoma Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Verma S, et al. Among authors: blackstein m. Cancer. 2008 Mar 15;112(6):1197-205. doi: 10.1002/cncr.23302. Cancer. 2008. PMID: 18224666 Free article. Review.
90 results